Bonraybio Co., Ltd. (TPE:6955)
88.00
-3.60 (-3.93%)
Nov 20, 2026, 1:08 PM CST
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 2.67 billion as of November 20, 2026. It is the 26,030th most valuable company in the world and the 1,350th biggest in Taiwan. Its market cap has decreased by 33.87% in one year.
Market Cap
2.67B
Enterprise Value
2.12B
Revenue
346.06M
Global Rank
Country Rank
#1,350 Taiwan
PE Ratio
25.27
ChartMarket Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 2.67B, an increase of 81.11%. That is a compound annual growth rate of 19.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.67B | -27.16% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hi-Clearance | 5.57B |
| Delta Asia International | 5.32B |
| WeLeader Biomedical | 3.22B |
| Apex Biotechnology | 2.87B |
| A Plus Biotechnology | 2.47B |
| Wellell | 2.46B |
| Applied BioCode | 2.24B |
| Dynamic Medical Technologies | 2.04B |